Hojjat Bazzazi

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Vascular Endothelial Growth Factor

Radiation Therapy

Tyrosine Kinase

Top Venues

ACS pharmacology & translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Zhang, Aleksander S Popel, Hojjat Bazzazi
Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies. ACS pharmacology & translational science 6 (5) (2023)
Yu Zhang, Aleksander S Popel, Hojjat Bazzazi
Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies. ACS pharmacology & translational science 6 (5) (2023)
Yu Zhang, Aleksander S Popel, Hojjat Bazzazi
Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies. ACS pharmacology & translational science 6 (5) (2023)